Newsletter | April 17, 2026

04.17.26 -- Building Smarter Cell Therapies With AI And Synthetic Biology

FOCUS ON CLINICAL TRIALS

Building Smarter Cell Therapies With AI And Synthetic Biology

Cell therapy development is entering a phase where complexity can no longer be managed by intuition alone. In this Cell & Gene Live, Chief Editor, Erin Harris, Timothy Lu, M.D., Ph.D, and Claire Aldridge, Ph.D., explore how AI and synthetic biology are being applied to engineer more precise, controllable, and scalable cell therapies.

Modernizing Clinical Data Review With AI

AI is transforming clinical data review by automating processes and enhancing efficiency. Discover the four stages of evolution that emphasize automation, regulatory alignment, data analysis, and human oversight.

How Smaller Biotechs Are Rethinking CRO Relationships Post-Pandemic

Smaller biotechs are rethinking CRO partnerships, valuing speed, scientific access, flexibility, and transparent pricing over scale — driven by pandemic lessons and a sharper focus on operational fit.

Tips For Navigating Health System Partnerships In CGT Commercialization

Collaborating with health systems is key to CGT commercialization. Gain insight into addressing operational and financial challenges to ensure processes are scalable and patient access is streamlined.

Accelerating Early Development With Integrated Data

How can you move faster from First-in-Human to Proof-of-Concept? Learn how integrating real-time manufacturing and clinical data removes the gaps that stall early development programs.

CLINICAL TRIALS SOLUTIONS

Eliminate Review Friction With An Industry-First IRB Platform - Univo IRB

Launching Bladder Cancer Trials In A Complex Clinical Landscape - Worldwide Oncology

Finding The Right CRO Partner For Early-Stage Oncology Trials - ClinAI

Connect With Cell & Gene: